[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639760":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":43,"collaborators":10,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Pregnant Women During Lactation Period",null,"Singleton pregnant women aged 18-50 years who conceived during the lactation period and were followed at participating obstetrics and gynecology clinics.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Burak D AYDOGDU, MD, OB\u002FGYN","CONTACT","+90 5396182228","burakd.1992@hotmail.com",[19,35],{"facility":20,"status":21,"city":22,"state":10,"zip":23,"country":24,"countryCode":10,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Prof. Dr. Cemil Taşcıoğlu City Hospital","RECRUITING","Istanbul","34384","Turkey (Türkiye)",{"type":26,"coordinates":27},"Point",[28,29],28.94966,41.01384,{"lat":29,"lon":28},[32],{"name":33,"role":15,"phone":34,"phoneExt":10,"email":17},"Burak d AYDOGDU, MD","90 5396182228",{"facility":36,"status":21,"city":22,"state":10,"zip":37,"country":24,"countryCode":10,"cosmosGeoPoint":38,"geoPoint":40,"contacts":41},"Esenyurt Necmi Kadıoğlu State Hospital","34517",{"type":26,"coordinates":39},[28,29],{"lat":29,"lon":28},[42],{"name":33,"role":15,"phone":16,"phoneExt":10,"email":17},{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Burak Deniz Aydoğdu","Principal Investigator","100639760","protective-effect-of-lactation-against-gestational-diabetes-mellitus-in-subsequent-pregnancies-a-prospective-observational-cohort-study-100639760",false,"NCT07624968","Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancies: A Prospective Observational Cohort Study","Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancy: A Prospective Observational Cohort Study","LACGDM","Inclusion Criteria:\n\n* Pregnant individuals aged 18 to 50 years.\n* Singleton pregnancy.\n* Conception during the lactation period.\n* Follow-up at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital.\n* Availability of glycemic parameters including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results.\n* Availability of routine ultrasonographic measurements including fetal abdominal circumference percentile (AC), estimated fetal weight percentile (EFW), and amniotic fluid index (AFI).\n\nExclusion Criteria:\n\n* Age below 18 years.\n* Age above 50 years.\n* Multiple pregnancy.\n* Known chronic systemic disease or pre-existing diabetes mellitus.\n* Missing clinical, laboratory, or ultrasonographic data.",true,"FEMALE","18 Years","50 Years",{"count":60,"type":61},140,"ESTIMATED","OBSERVATIONAL","Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with increased maternal and fetal morbidity. Lactation has been suggested to improve maternal glucose metabolism, enhance insulin sensitivity, and reduce the risk of future glucose intolerance. However, evidence regarding the protective effect of lactation on the development of GDM in subsequent pregnancies remains limited.\n\nThis prospective observational cohort study aims to evaluate the association between lactation and the risk of gestational diabetes mellitus and related pregnancy complications in women who conceive during the lactation period. Routine glycemic markers including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results will be recorded. Ultrasonographic findings including fetal abdominal circumference percentile, estimated fetal weight percentile, and amniotic fluid index will also be assessed. The study will investigate whether lactation is associated with a reduced risk of GDM, fetal macrosomia, and polyhydramnios in subsequent pregnancies.",[65,66],"Gestational Diabetes Mellitus (GDM)","Lactating Mother",[68],"Gestational Diabetes Mellitus,Lactation,Breastfeeding,Glucose Metabolism,Maternal Health","2026-05-29",{"date":71,"type":72},"2026-06-03","ACTUAL",{"date":74,"type":72},"2026-01-15",{"date":76,"type":61},"2027-12-31",{"name":5,"class":6},2]